Day 1 – Physician Meet – Scientific Program
Thursday, October 26th 2023
Basic Hematopoietic Stem Cell Transplant
| 08.00 AM – 09.00 AM |
Session 1 Chairman: Bambang Sudarmanto, MD (Semarang) |
| 08.00 AM – 08.20 AM |
Indications and Results of HCT in Leukemia |
| 08.20 AM – 08.40 AM |
Indications and Results of HCT in MM |
| 08.40 AM – 09.00 AM | Discussion |
| 09.00 AM – 10.00 AM |
Session 2 Chairman : Mika L. Tobing, MD (Semarang) |
| 09.00 AM – 09.20 AM |
Biological Properties of HSC: Scientific Basis for HSCT |
| 09.20 AM – 09.40 AM |
Criteria of Donor Choice. Matched Unrelated Donor vs Haploidentical Donor vs Cord Blood & Principles of HLA Typing for the Clinician |
| 09.40 AM – 10.00 AM | Discussion |
| 09.40 AM – 10.00 AM | Coffee Break |
| 10.00 AM – 11.00 AM |
Session 3 Chairman : Putu Niken Ayu Amrita, MD (Surabaya) |
| 10.00 AM – 10.20 AM |
Mobilization for Peripheral Blood Stem Cell Collecting |
| 10.20 AM – 10.40 AM |
Conditioning Regimens. Reduced Intensity vs Myeloablative |
| 10.40 AM – 11.00 AM | Discussion |
| 11.00 AM – 12.00 AM |
Session 4 Chairman : Cosphiadi Irawan, MD, Ph.D (Jakarta) |
| 11.00 AM – 11.20 AM |
Early and Late Complications after HCT |
| 11.20 AM – 11.40 AM |
Blood Support during HSCT |
| 11.40 AM – 12.00 PM | Discussion |
| 12.00 AM – 01.00 PM |
Industry Lunch Symposium Chairman : Damai Santosa, MD, Ph.D (Semarang) |
| 12.00 AM – 12.40 PM |
Smart To Manage HSCT Patient with Invasive Fungal Infections |
| 12.40 PM – 01.00 PM | Discussion |
| 01.00 PM – 01.40 PM | Update of Classical Hodgkin Lymphoma |
| 01.00 PM – 01.20 PM |
Real-world Outcomes of Brentuximab Vedotin in Relapsed/Refractory Classical Hodgkin lymphoma |
| 01.20 PM – 01.40 PM | Discussion |
| 01.40 PM – 02.40 PM |
Updates on CLL Management |
| 01.40 PM – 02.00 PM |
New Approach Treatment: Acalabrutinib Second Generation BTKi Update for Naive and R/R CLL patient with/without High-Risk Factor |
| 02.00 PM – 02.20 PM |
Role of Clinical & Molecular Laboratory in Chronic Lymphocytic Leukemia : Updates on International Guidelines and Building National Capacity |
| 02.20 PM – 02.40 PM | Discussion |
